Skip to content
10-Q/A

Quarterly Report

Dougherty's Pharmacy, Inc.

0001683168-19-001703

← back to feed
Filed
May 23, 2019 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 15, 2019 23.1M sh
Capex Q1 2019 · Mar 31, 2019 $5K
Capex Q1 2019 · Mar 31, 2018 $75K
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$108K
Operating Cash Flow Q1 2019 · Mar 31, 2018 $150K
Long Term Debt Q1 2019 · Mar 31, 2019 $2.1M
Long Term Debt Q1 2019 · Dec 31, 2018 $2.1M
Short Term Debt Q1 2019 · Mar 31, 2019 $4.78M
Short Term Debt Q1 2019 · Dec 31, 2018 $4.84M
Stockholders Equity Q1 2019 · Mar 31, 2019 −$2.4M
Stockholders Equity Q1 2019 · Dec 31, 2018 −$1.9M
Stockholders Equity restated Q1 2019 · Dec 31, 2017 $1.63K
Current Liabilities Q1 2019 · Mar 31, 2019 $8.76M
Current Liabilities Q1 2019 · Dec 31, 2018 $8.27M
Total Liabilities Q1 2019 · Mar 31, 2019 $15.01M
Total Liabilities Q1 2019 · Dec 31, 2018 $10.36M
Current Assets Q1 2019 · Mar 31, 2019 $4.74M
Current Assets Q1 2019 · Dec 31, 2018 $4.9M
Total Assets Q1 2019 · Mar 31, 2019 $12.61M
Total Assets Q1 2019 · Dec 31, 2018 $8.46M
Sga Expense Q1 2019 · Mar 31, 2019 $2.17M
Sga Expense Q1 2019 · Mar 31, 2018 $2.52M
Net Income Q1 2019 · Mar 31, 2019 −$498K
Net Income Q1 2019 · Dec 31, 2018 −$3.53K
Net Income Q1 2019 · Mar 31, 2018 −$266K
Operating Income Q1 2019 · Mar 31, 2019 −$381K
Operating Income Q1 2019 · Mar 31, 2018 −$183K
Gross Profit Q1 2019 · Mar 31, 2019 $2.01M
Gross Profit Q1 2019 · Mar 31, 2018 $2.57M
Cost Of Revenue Q1 2019 · Mar 31, 2019 $5.75M
Cost Of Revenue Q1 2019 · Mar 31, 2018 $6.89M
Revenue Q1 2019 · Mar 31, 2019 $7.77M
Revenue Q1 2019 · Mar 31, 2018 $9.46M